EDGAR·FLOW

Advanced Biomed Inc. — Form 8-K

Filed November 20, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 4/100
What the filing says
Advanced Biomed Inc. (Nevada corp, Taiwan operations) agreed to sell up to 320,000 shares of common stock at $0.35/share ($112,000 total) to unnamed accredited/non-U.S. investors under Reg D/Reg S exemption. Agreement dated November 20, 2026; closing within 2 business days. Company has 1,652,133 shares outstanding pre-placement; 400M authorized. No counterparty names, amounts per investor, or final closing details disclosed in this form.
Why this rating

Capital raise of ~$112K is 4.1% of company's $2.7M market value—modest for a micro-cap. Standard private placement with no unique terms or conditions disclosed. Routine financing activity for small public company.

View original filing on SEC.gov ↗ ADVB · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.